Pearl Diagnostics, Inc.
Baltimore, MD
- UEI
- N9CGVFYJM1B5
- CAGE
- 731Y0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1812 Ashland Ave #100, Baltimore, MD 21205, USA
- Website
- pearldx.com
- Founded
- 2014
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A point of care urine test to aid diagnosis of aspergillosis - invasive aspergillosis (IA) was recently named by the who… | National Institute of Allergy and Infectious Diseases | $2,953,458 | |
| Mycomeia - urine diagnostic for aspergillosis - aspergillosis causes morbidity and death in medically immune compromised… | National Institute of Allergy and Infectious Diseases | $2,929,728 | |
| Sbir phase i: novel and enhanced urine test for the detection of the fungal infection aspergillosis | National Science Foundation | $174,999 | |
| Urine diagnostics for aspergillosis | National Institutes of Health | $238,175 | |
| Urine diagnostics for aspergillosis | National Institute of Allergy and Infectious Diseases | $1,844,235 |
About Pearl Diagnostics, Inc.
Pearl Diagnostics, Inc. is a Baltimore-based, woman-owned small business specializing in developing innovative in vitro diagnostic (IVD) tests for detecting complex lung infections. The company focuses on creating non-invasive diagnostic technologies that leverage unique approaches to identifying microbial pathogens, particularly through urine-based testing methods. Registered in SAM.gov since 2014, Pearl Diagnostics is a for-profit corporate entity that provides advanced diagnostic solutions to federal agencies, with a primary emphasis on developing rapid, point-of-care diagnostic tests for challenging infectious diseases.
Through federal contract sub-awards, Pearl Diagnostics has worked on developing diagnostic technologies for identifying specific lung pathogens, particularly focusing on complex pneumonia cases. In a December 2024 sub-contract award with Trustees of Boston University, the company demonstrated expertise in developing diagnostic technologies to identify Pseudomonas aeruginosa (PSA) in pneumonia cases. The sub-contract work highlighted Pearl Diagnostics' capabilities in addressing antimicrobial drug resistance challenges, with a specific focus on creating diagnostic solutions that can quickly and accurately identify pathogens in high-risk patient populations, including those with conditions like cystic fibrosis and bronchiectasis.
Pearl Diagnostics has secured significant federal grant awards from the National Institute of Allergy and Infectious Diseases (NIAID), primarily focused on developing advanced diagnostic tests for invasive aspergillosis. In a July 2025 project grant award totaling $999,316, the company is developing a rapid, point-of-care urine test for diagnosing invasive aspergillosis, a critical public health threat. An earlier March 2021 grant supported the development of MycoMEIA, a prototype enzyme immunoassay designed to detect fungal infections in immunocompromised patients, particularly those undergoing cancer treatments or organ transplants. These grant-funded projects demonstrate Pearl Diagnostics' commitment to creating innovative diagnostic technologies that can improve early detection and treatment of complex infectious diseases, with a particular emphasis on developing urine-based diagnostic tests that offer high sensitivity and specificity.
SBA capabilities narrative
Research and development of in vitro diagnostics
Quick answers
What is Pearl Diagnostics, Inc.'s UEI?
Pearl Diagnostics, Inc.'s Unique Entity ID (UEI) in SAM.gov is N9CGVFYJM1B5.
What is Pearl Diagnostics, Inc.'s CAGE code?
Pearl Diagnostics, Inc.'s CAGE code is 731Y0.
What is Pearl Diagnostics, Inc.'s primary NAICS code?
Pearl Diagnostics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Pearl Diagnostics, Inc. located?
Pearl Diagnostics, Inc.'s physical address in SAM.gov is 1812 Ashland Ave #100, Baltimore, MD 21205, USA.
Is Pearl Diagnostics, Inc. registered in SAM.gov?
Yes. Pearl Diagnostics, Inc.'s SAM.gov registration is active through August 19, 2027.
What is Pearl Diagnostics, Inc.'s most recent federal award?
Pearl Diagnostics, Inc.'s most recent federal grant award is A point of care urine test to aid diagnosis of aspergillosis - invasive aspergillosis (IA) was recently named by the who… (SB1AI186689), from National Institute of Allergy and Infectious Diseases, on July 24, 2025.
On GovTribe
See Pearl Diagnostics, Inc.'s full federal record
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors